[email protected]/(408) 457-3700

About RapiDx

"With RapiDx solution they can do it whenever they want, wherever they want, including at home.

RapiDx develops a device called RapTest, which is platform suitable for an array of health conditions. The first application of this platform is HIV self-test which can save the lives of millions.

RapiDx will break-even in 3years and show positive cash flow within 2years of initiating sales

RapiDx successfully completed a clinical trial, and received FDA clearance for a component of its system, its RapidRing. Moreover, RapiDx holds 2 patents in various territories covering its technology.

After a seed round of $1M that was completed in 2011 we are now looking now for Round A investment that will bring its product to the market.


You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Tel Aviv, Israel
Medical Devices
Therapeutic Areas:
Infectious Diseases, Other